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Bioengineered vascular graft grown in the mouse
peritoneal cavity
Lei Song, MD, Lai Wang, MD, Prediman K. Shah, MD, Aurelio Chaux, MD, and
Behrooz G. Sharifi, PhD, Los Angeles, Calif
Background: We tested the hypothesis that the mouse peritoneum can function like a bioreactor to generate directed
bio-engineered tissues such as those used for bypass grafting. Additionally, we reasoned that the mouse animal model
would allow us to elucidate the underlying cellular and molecular mechanisms that are responsible for the generation of
tissue in peritoneal cavity.
Methods: Plastic tubes (two tubes/mouse) were implanted into the peritoneal cavity of three strains of mice (C57BL/6,
BALB/c, and MRL). The tubes were harvested, tissue capsule surrounding the tubes was removed, and analyzed by
immunostaining (five capsules/five mice/strain) and microarray (three capsules/three mice/strain). In addition, the
tissue capsules that were harvested from MRL mice (n  21) were grafted into abdominal aorta of the same mice as
autografts. The patency of all grafts was monitored by micro-ultrasound, and their functionality was assessed by laser
Doppler imaging of blood flow in femoral arteries. Venous (n  13) and arterial isografts (n  11) were used as positive
controls. In a negative control group (five mice/strain), the abdominal aorta was occluded by double ligation with 9-0
silk.
Results: The implanted plastic tubes required at least 8 weeks of incubation in the peritoneum of the three strains of mice
in order to generate useful grafts. No vascular cells were found in the tissue capsules. Microarray analysis of tissue capsules
revealed that the capsular cells express a gene expression program that is vastly shared among the three strains of mice, and
the cells exhibit a high degree of plasticity. The micro-ultrasound analysis of the grafts showed that 62% of autografts
remained patent compared with 77% of venous isografts and 91% of arterial isografts. The laser Doppler imaging analysis
showed that blood flow dropped by 40% and 35% in the autografts and vein isografts, respectively, 1 day after surgery.
The flow, however, rebounded to the level of arterial isografts 1 month post-surgery and remained unchanged among all
grafts for the next 4 months. Immunostaining of the autografts showed a thick vessel wall with endothelial cells that lined
the lumen and smooth muscle cells that constituted the graft wall.
Conclusion: The mouse peritoneal cavity of mice has the ability to function like a bioreactor to generate bio-engineered
tissues. The tissue capsules harvested from peritoneal cavity of a mouse are composed of nonvascular cells that display
phenotype of progenitor cells. After grafting, however, the capsule autografts become arterialized and remained patent
for at least 4 months after surgery, similar to venous or arterial isografts. ( J Vasc Surg 2010;52:994-1002.)
Clinical Relevance: This animal model will facilitate the understanding of the genetic, molecular, and functional bases of
vascular graft remodeling; specifically, the role of progenitor vascular cells in the arterialization of grafts without the
interference from the residing vascular cells.Vascular bypass grafting is the mainstay of revascular-
ization for ischemic heart disease and peripheral vascular
disease, and in the United States alone, 1.4 million arterial
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994bypass operations are performed annually. However, 30%
of patients who require arterial bypass procedures do not
have saphenous veins suitable for use, because of previous
harvest for bypass surgery, varicose degeneration, or inad-
equate diameter or length.1 Campbell et al showed that
implantation of silastic tubing into the peritoneal cavities of
dogs, rabbits, and rats led to the formation of free-floating
avascular tissue tubes over 2 weeks, with few intestinal
adhesions.2-4 Investigations into the underlying molecular
mechanisms of tissue capsule generation in the peritoneal
cavity and their application as a functional graft have been
hampered by the non-murine nature of animal model.
The objective of the present study was to refine amouse
model allowing the development of a peritoneal-derived
capsule graft that would facilitate a study of the genetic and
molecular characteristics of the graft. We hypothesized that
the mouse peritoneum can function like a bioreactor gen-
erating directed bio-engineered tissue that can be used for
grafting in a similar way to venous or arterial grafts. By
employing three strains of mice, we were able to analyze
gene expression program underlying development of tis-
lease
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Doppler image analyses were used to evaluate the function
of grafts.
MATERIALS AND METHODS
Eight mm lengths of plastic tubes were implanted into
the peritoneal cavity of three strains of mice. The tissue
capsule that formed over the tube during the incubation
was used for microarray analysis and immunostaining. The
tissue capsules harvested from MRL mice were grafted by
end-to-end anastomosis into the abdominal aorta of the
same mice as autografts. Venous and arterial isografts were
used as positive controls. Immunohistochemical staining
and expression profiling were used to characterize the
cellular composition of tissue capsule. Micro-ultrasound
imaging and laser Doppler imaging assessed the function-
ality of the capsule grafts. Detailed methodologies are
described in the Appendix (online only).
RESULTS
To test the hypothesis that the mouse peritoneum can
function like a bioreactor to generate capsule grafts, two
8-mm-long sialistic tubes (outer diameter, 0.96 mm) were
implanted into the peritoneal cavity of C57BL/6 mice and
harvested after 2 weeks, as per Campbell’s3 recommenda-
tion (Fig 1, panel A). However, only two ends of the tubes
were found to be covered with proteineousmaterial and the
midsection of tube remained uncovered (Fig 1, panel B; the
arrows indicates the areas that are not covered). Subse-
quently, we found that an incubation period of least 8
weeks was required to generate a tissue capsule that was
Fig 1. Generation of tissue capsule in the peritoneal cav
cavity of C57BL/6 mice and removed 14 days after imp
with tissues, whereas the midsection of the tube remaine
harvested after 8 weeks, which is completely covered with
tube by cutting one end of the capsule. E shows the ha
autografting into the abdominal aorta of a mouse. Simil
For details on the number of tubes and methodology, psuitable for grafting (Fig 1, panel C). The tissue capsulethat formed around the tubes was carefully separated from
the tube (Fig 1, panel D) and used for grafting.
Since our goal was to use the tissue capsule for bypass
grafting, we asked whether the harvested capsules exhibit a
phenotype of blood vessel conduits. To explore this, the
harvested capsules were stained by antibodies that are spe-
cific to smooth muscle -actin and an endothelial cell-
specific marker CD31. We found that the capsule contains
cells that are unevenly distributed; however, these cells did
not express either smooth muscle marker (Fig 2A) or
endothelial cell marker (Fig 2B). This suggests that the
tissue capsules harvested from the mouse peritoneum lack
cells with a vascular cell phenotype. In addition, few mac-
rophages were observed in only one of the capsules prior to
grafting (Fig 2C, arrow), suggesting that inflammationmay
not be a major player in the formation of tissue capsule.
Collagen staining revealed that the capsules are composed
of collagenous material (Fig 2D).
To characterize the phenotype of cells that were found
in the tissue capsule, total RNA was extracted from freshly
harvested capsules from three BALB/c mice, three
C57BL/6 mice, and three MRL strains of mice, and total
RNAs were analyzed bymicroarray. The detailed analysis of
quality of RNA isolated from tissue capsules of each strain
of mice, their intra-group reproducibility scatter plot anal-
ysis, and the gene lists are included in the Appendix (online
only).
Since we were able to grow complete tissue capsules in
the peritoneal cavity of C57BL/6, BALB/c, and MRL
mouse strains, we reasoned that the process of capsule
generation in the peritoneum of the three strains of mice is
a mouse. Siastic tubing (A) was inserted into peritoneal
tion. B shows that the two ends of the tube are covered
covered (arrows). C shows the implanted tube that was
e.D illustrates the removal of the tissue capsule from the
ed plastic tube and the tissue capsule that was used for
ults were obtained with implanted polyethylene tubing.
see the Method section in the Appendix (online only).ity of
lanta
d un
tissu
rvest
ar reslikely controlled by a gene expression program that is
in the
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of overlapping genes among the three strains of mice
allowed us to filter out non-relevant, strain-specific genes.
To explore this idea, gene expression profile of tissue cap-
sules harvested from the three strains of mice were com-
pared and the shared gene expression program was identi-
fied. In addition to strain-specific genes, we identified a
subset of genes commonly enriched among the three
strains of mice (Fig 3A). The probability of observing
such an overlap by chance as estimated using hypergeo-
metrical distribution5 is extremely low (P  10-11). The
distribution of genes within the shared transcriptome
across functional categories is shown in Fig 3B. Mole-
cules thought to be involved in development, morpho-
genesis, and differentiation tend to be overrepresented in
the shared gene expression program of tissue capsule
cells. These results suggest that there is a gene expression
program in the peritoneal-derived tissue that is shared
among the three strains of mice, and that this program is
indicative of a high degree of plasticity in the phenotype
of capsular cells.
Next, we evaluated the ability of tissue capsules to
function as a bypass autograft when compared with venous
or arterial isografts. For this evaluation, we used only MRL
mice because they are 50% larger than the other two strains
of mice, making surgical manipulations easier. The tissue
capsules harvested from 21 MRL mice were grafted into
abdominal aorta of the same mice by an end-to-end anas-
tomosis, as autografts. The photograph of tissue capsule
immediately after grafting is shown in Fig 4, panel A; the
arrow illustrates that the surface of the capsule grafts is
smooth. The capsule autografts were harvested 4 months
after grafting (Fig 4, panel B; arrow). Two positive controls
were used: a venous isograft (Fig 4, panel C; arrow), and an
arterial isograft (Fig 4, panel D; arrow); the donor and
recipient mice are MRL mice (ie, the grafts are isografts).
Fig 2. Representative immunohistochemical analysis of
at 8 weeks from the peritoneum of MRL mice were stain
(A), 1:50 dilution of anti-CD31 antibody (B), and 1:50
the sections from the three strains of mice were negativ
mouse was positive for moma-2 expression (arrow).D sh
harvested from each strain of mice. See method sectionFor the number of grafts and patency rate, see the Table.For the negative control group, the abdominal aorta of
MRL mice was occluded by double ligation with 9-0 silk.
All mice from the negative control group lost their ability to
move shortly after surgery and had to be euthanized,
whereas the majority of the mice receiving capsule au-
tografts and the two positive control groups of mice receiv-
ing venous or arterial isografts remained mobile, vigorous,
and viable.
We used three methodologies to assess patency of the
grafts. The graft was considered successful if it met the
following criteria: at the time of implantation and harvest-
ing, it was strongly pulsating and fully distended; the ani-
mal had normal motor activity; and the graft was patent as
indicated by a good blood flow through the graft, as well as
through both femoral arteries. In addition, subsequent
immunostaining examination of the sections showed no
evidence of clot formation. Conversely, grafts that were not
patent were flaccid, retracted, and had no detectable pulsa-
tion. Microscopically, they clearly showed a clot in their
lumen. Using these criteria, MRL mice with successful
grafts were retained for investigations. The viability rate/
patency rate among the recipient of capsule autografts,
venous isografts, and arterial isografts was 60%, 76%, and
90%, respectively (Table). A representative micro-ultrasound
image of 4-month-old capsule graft in the abdominal aorta
of MRL mice (Fig 5) indicates that the capsule grafts
remained distended with an average length of 7.38mm and
diameter of 1.23 mm, as shown in Fig 5, panels A and B,
respectively. Pulse wave Doppler shown in Fig 5, panel C,
illustrates good blood flow consistent with the results of
laser Doppler imaging.
In addition to micro-ultrasound, we used laser Doppler
imaging to assess the ability of grafts to perfuse the lower
extremities of mice. As shown in Fig 6A, blood flow to the
femoral artery was significantly reduced 1 day post-surgery
in the capsule autograft recipients (Fig 6A, panel II) or
capsule. The frozen sections of tissue capsule harvested
th 1:50 dilution of anti-smooth muscle -actin antibody
on of anti-MOMA-2 antibody (C). The vast majority of
MOMA-2 expression, and only one section from one
ollagen staining. We stained five tissue capsules that were
Appendix (online only) for details.tissue
ed wi
diluti
e for
ows cvenous isografts recipients (Fig 6A, panel V) compared
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Volume 52, Number 4 Song et al 997Fig 3. Expression profiling of freshly-harvested tissue capsules isolated from the three strains of mice. Total RNA was
isolated from freshly-harvested tissue capsule from the three strains of mice (three mice/strain), and after pooling and
quality control evaluation, they were analyzed by microarray using mouse Affymetrix GeneChip MOE-430 (Af-
fymetrix, Santa Clara, CA) that contains 22,000 cDNA and ESTs. A, Venn diagram showing the number of genes
enriched in each strain-specific cell population and their overlaps. Note the high overlap between the three strains of
mice. In a small percentage of the cases, the same gene is recognized bymore than one probe set in the Affymetrix array;
hence, the 669 probe sets enriched in all peritoneal cells actually correspond to 628 unique genes. B shows the
distribution within the shared transcriptome for gene products with known or putative functions.
able.
r analy
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respectively), whereas the perfusion of recipients of arterial
isografts (Fig 6A, panel VIII) appeared to be greater than
that of other grafts. The blood flow in all types of graft
recipients was similar at 1 month post grafting (Fig 6A,
panels III, VI, and IX). Quantitative analysis of blood flow
in the recipient mice shown in Fig 6B revealed that the
average blood flow in the recipients of either capsule au-
tografts or vein isografts groups dropped by 40% (2.19 
0.13 vs 1.29  0.24) and 35% (2.21  0.01 vs 1.43 
0.27), respectively, at 1 day post-surgery. In contrast, no
statistically significant difference was found in the blood
flow of mice that received arterial isografts (2.2  0.09 vs
Fig 4. Grafting of tissue capsule into abdominal aorta o
everted and grafted into abdominal aorta of the same
smoothness of the surface of the graft (arrow). B shows t
show venous isografts (arrow) and arterial isografts (arrow
patency rate, and animal survival rate are shown in the T
Table. Graft statistics
Graft type
4 weeks
(patent grafts)
Capsule grafts (autograft) 8
Vein grafts (isograft) 5
Arterial grafts (isograft) 5
All grafting was performed in MRL mice. Tissue capsules harvested from th
arterial grafts that were used as positive controls, vena cava and thoracic a
recipient MRL mice (ie, these grafts are isografts). The total number of vein
animals. We used these numbers in order to obtain at least five surviving anim
each group of animals 4 weeks and then 16 weeks post-surgery and used fo1.79  0.1). At 4 weeks post-grafting, however, the flowrebounded in the recipients of both capsule autografts and
venous isografts. Similarly, no significant differences in the
blood flow were detected in all three groups of graft recip-
ients at 4 months after grafting.
To assess the cellular composition of the capsule au-
tografts, the mice were sacrificed at 4 months (n  5), the
grafts were harvested, snap-frozen, embedded in optimal
cutting temperature, sectioned, and analyzed by immuno-
histochemical staining (Fig 7).Movat staining revealed that
the wall of capsule autografts was thick with multiple layers
of cells that were distributed throughout the graft (Fig 7,
panel A). In contrast to tissue capsule before grafting (Fig
2), we did not find any acellular regions in the capsule
same MRL mice. A, Freshly harvested tissue capsule was
(ie, the capsule grafts are autografts). Please note the
psule autograft 4 months after transplantation. C and D
onths after grafting, respectively. The number of grafts,
16 weeks
tent grafts) Total exp. Survival rate
5 21 13/21 (61.9%)
5 13 10/13 (76.9%)
5 11 10/11 (90.9%)
itoneum of 21 MRL mice were grafted into the same animal. For vein and
arvested from donor MRL mice were grafted into abdominal aorta of the
performed was 13 animals, and for arterial grafts, the total number was 11
tent grafts) at 4 and 16 weeks post-surgery. The grafts were harvested from
sis.f the
mice
he ca
) 4 m(pa
e per
orta h
grafts
al (paautografts. The cells that formed the thick wall of the
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ish color). Unlike the staining of freshly harvested tissue
capsules (Fig 2), the autografts strongly expressed markers
of smooth muscle -actin that are concentrated in the
thickened wall (Fig 7, panel B). The expression pattern of
smooth muscle cell markers in the autografts was similar to
those of positive control vein isografts that are known to be
arterialized when exposed to arterial pressure (Fig 7, panel
C). The autografts expressed endothelial cell markers, sug-
gesting that endothelial cells lined the lumen of the capsule
grafts (Fig 7, panel D). The autografts expressed little, if
any, macrophage markers (Fig 7, panel E), suggesting that
the grafts were not inflamed. These data suggest that the
harvested tissue capsules were basically acellular before
grafting; however, they displayed phenotype of vascular-
ized blood vessel conduit when they were grafted into
abdominal aorta for at least 4 months.
DISCUSSION
The peritoneal cavity of several different animal species
has been used to develop artificial grafts4,6; however, those
studies utilized a non-murine model that precluded analysis
of these grafts at the genetic and molecular levels. To
overcome this limitation and to test the hypothesis that the
mouse peritoneal cavity has an environment that is condu-
Fig 5. Representative micro-ultrasound analysis of the
to evaluate patency of the capsule graft 4 months afte
autografts remained distended with average length of 7
measured by pulse wave Doppler.cive to the formation of artificial blood vessels, we havedeveloped a mouse model where the artificial conduit is
grown within the peritoneal cavity. To accomplish this
goal, we initially followed the Campbell’s protocol3 by
harvesting the implanted silastic tubes 2 weeks after implan-
tation into the mouse peritoneum; however, the harvested
tubes were found to be incompletely covered with the
tissues that were not suitable for grafting. This was a
consistent observation among the three strains of mice
examined, suggesting that the incomplete formation of
tube under this condition is independent of mouse strain.
Further studies revealed that by extending the incubation
time of the tubes in the mouse peritoneum to 8 weeks,
tissue capsules that were generated were suitable for graft-
ing. Immunohistochemical analysis revealed that the tissue
capsules isolated from the peritoneal cavity of BALB/c
mice, C57BL/6 mice, or MRL mice contained few cells,
and these cells did not express vascular cell markers.
To generate a hypothesis about the nature of cells that
contribute to the formation of a tissue capsule in the mouse
peritoneum, we examined the expression profile we estab-
lished from total RNA harvested from the freshly-harvested
capsules following an 8-week incubation in the mouse
peritoneum. As all three strains of mice were capable of
generating tissue capsule, we reasoned that the peritoneal
cavities of C57BL/6, BALB/c, and MRL mice share tran-
ent of the capsule graft. The micro-ultrasound was used
fting in MRL mouse. A and B show that the capsule
m and diameter of 1.23 mm. C shows blood flow asrecipi
r gra
.38 mscriptome signatures that allow these mice to generate
see t
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signature gene expression program allowed us to filter out
strain-specific gene expression program and exclude non-
relevant transcriptome that is unlikely to be involved in
tissue capsule formation. Using a Venn diagram, we noted
that the vast majority of genes found in the tissue capsules
derived from the three strains of mice displayed extensive
overlap, suggesting that all the tissue capsules generated are
very similar to one another and likely represent the results
of a conserved gene expression program. The profiling data
also revealed that the tissue capsules shared a transcriptome
profile that is similar to progenitor cells. Among the 669
Fig 6. Representative laser Doppler images from the b
arterial grafts. A, The laser Doppler images were recorde
day, and 1 month after grafting in MRL mice. Images
compared with those of baseline (I). Similarly, venous g
were compared with their respective baseline images (IV
reflect red blood cell velocity (red is highest velocity, gr
results of laser Doppler image-derived blood flow of th
course. Each data point represents the mean value  SD
.05), and the capsule graft (CG) is compared with arteri
a detailed number of grafts and the patency rates, pleaseup-regulated genes that are shared among the capsulegrafts, the vast majority of them are related to the develop-
ment, differentiation, and morphogenesis; a genotype that
is similar to those of progenitor cells. These data suggest
that the peritoneal cells that contributed to the formation
of tissue capsule may exhibit a high degree of plasticity,
which allows these cells to adopt the phenotype of vascular
cells when exposed to conditions that are conducive to the
formation of a vascular cell phenotype, such as grafting of
tissue capsules into arterial circulation. If this proves cor-
rect, one could speculate that the peritoneum most likely
contains progenitor cells with the ability to home in, cover
the plastic tubes, and generate tissue capsules with the
al hind limbs of the recipients of capsule, venous, and
hree different times: 1 day prior to grafting (baseline), 1
of hind limbs with the capsule graft (II and III) were
and VI) as well as arterial graft images (VIII and IX)
VII), respectively. Representative color-coded images
ntermediate, and blue, lowest velocity). B, Cumulative
teral hind limbs are shown over the experimental time
ous graft (VG) is compared with arterial graft (AG; P 
ft (AG; P  .01) at 1 day following transplantation. For
he Table.ilater
d at t
taken
raft (V
and
een i
e bila
. Ven
al graability to function as blood vessel conduits. In addition,
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tissue capsule are not differentiated cells, a finding that is
supported by immunohistochemical analysis of the capsule
grafts. Further, the shared transcriptome profile does not
support the concept that the capsular cells exhibit pheno-
type of fibroblasts. Overall, the microarray data coupled
with immunostaining analysis of tissue capsules point to the
plastic nature of capsular cells. Studies are underway to
explore this hypothesis in depth.
We found that when the tissue capsules harvested from
MRL mice were grafted into abdominal aorta, blood flow
dropped approximately by 40% in the first day after surgery,
as compared with arterial grafts. A similar drop, 35%, in the
blood flow was also observed when venous grafts were
used. Over a period of 4 weeks, however, no statistically
significant difference was found in the blood flow among all
the recipient groups. The initial drop in the blood flow
among the recipient of capsule grafts and vein grafts is likely
related to the delay in flow-induced remodeling of the
grafts (ie, arterialization). The differences in the venous and
arterial pressures are thought to be responsible for the
remodeling of vein grafts inducing proliferation of pre-
existing venous smooth muscle cells that foster a thick
media.7 While this notion is applicable to remodeling of
vein grafts that contain vascular cells, it would not be
applicable to capsule autografts because immunostaining
and microarray analyses found no vascular cell phenotype
characteristics in the tissue capsule before grafting. We
believe that the experimental arterialization that has been
described for vein isografts in animal models is likely differ-
ent from the arterialization of tissue capsule autografts, for
at least two reasons. First, unlike isografts, capsule au-
tografts do not generate a significant immune response to
the grafts; therefore, the contribution of inflammatory-
derived cells/factors is not a prominent factor/s in the
remodeling of capsule grafts. Second, the vein grafts con-
Fig 7. Representative immunohistochemical analysis of
MRL mice. Frozen sections harvested from five MRL m
staining and immunostaining.A showsMovat staining.B
venous isografts, respectively.D shows staining of capsule
The presence of macrophages was evaluated by anti-MO
five venous isografts, and five aortic isografts.tain endothelial cells and smooth muscle cells that canproliferate in response to arterial pressure and develop into
artery-like structures. Such a possibility does not exist for
capsule grafts because there are no vascular cells in the
capsule before grafting. Therefore, we feel that the capsular
remodeling is unique and most likely related to the adap-
tation remodeling of progenitor cells to the arterial pres-
sure, the consequence of which is formation of capsule
grafts, which function like those vein grafts and arterial
grafts.
The origin of vascular cells in the capsule grafts remains
unclear at this time. The cells may have originated from
local progenitor cells residing within the local capsular
autograft vessel wall or from circulating progenitor cells.
While some studies have shown that endothelial progenitor
cells contribute to the repair of the damaged blood vessels,
foster bioengineering of vascular prosthetic grafts and
stents,8,9 and contribute to the remodeling of graft in a
parabiotic mousemodel,10 other studies found no evidence
for such a contribution of bone marrow-derived cells.11,12
The reason for this divergent data remains unclear; how-
ever, reliable identification of the phenotype and origin or
lineages of cells requires careful examination and localiza-
tion of cell markers to a single cell. With a thickness of less
than a few microns, co-localization studies involving single
cells are particularly demanding and may not be reliable.
Further studies will be needed to address this fundamental
question.
In summary, we have developed a mouse model for
generation of artificial grafts that can be used effectively for
grafting. The grafts remained patent when grafted into
abdominal aorta, and they become arterialized. The tissue
capsules before grafting were primarily composed of non-
vascular cells and collagen; however, endothelial cells were
found to line the lumen, and multilayer smooth muscle
cells were found in the “wall” after autografting of the
tissue capsule. Gene expression profiling showed that
apsule graft harvested 4 months after transplantation in
issue capsule autografts were analyzed by histochemical
C show smoothmuscle -actin staining of autografts and
graft for the expression of CD31 endothelial cell marker.
2 staining (E). We stained five tissue capsule autografts,the c
ice t
and
auto
MA-the tissue capsule cells express a phenotype that exhibits a
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with an opportunity to investigate the cellular and molec-
ular basis of graft remodeling, specifically the contribution
of resident peritoneal cells and circulating progenitor cells
in this process.
We thank Ian Williamson for his assistance in the prep-
aration of the manuscript. BGS is an established investiga-
tor of the American Heart Association.
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The BALB/c, C57BL/6, and MRL/MpJ/ mice
were purchased from Jackson Laboratories (Bar Harbor,
Me). Themice were maintained on a light/dark (12-hour/
12-hour) cycle at 25°C, and received regular mouse chow
and water ad libitum before experimentation. All the pro-
cedures were standardized and approved by the IACUC
Committee of Cedars-Sinai Medical Center.
Implantation of plastic tubes into mouse peritoneal
cavity
The mice were anesthetized with 2.5% Avertin (0.015
ml/gm) by intra-peritoneal injection, and pre-medicated
with Carprofen (5 mg/kg, subcutaneously). The skin was
prepared by shaving with electric clippers and the applica-
tion of betadyne solution; through a small abdominal inci-
sion, two silicon tubings (Cat # BS4 72-1043, ID: 0.5 mm,
OD: 0.9 mm; Harvard Apparatus, Holliston, Mass) were
inserted into the peritoneal cavity of each mouse, two
tubes/mouse. The peritoneum and the skin were closed in
layers with interrupted sutures. The mice were kept warm
by a heating pad and given warm fluids as needed during
the recovery period. The tubes were harvested at indi-
cated times after implantation. The implants were harvested
through a larger midline abdominal incision, to facilitate
the subsequent transplantation. Generally, of the two im-
planted tubes, only one is floating and is useful for grafting
(three mice/strain). The tissue capsules were harvested at
the indicated time after implantation. For microarray anal-
ysis and immunostaining, we collected eight floating tissue
capsules from C57BL/6, eight tissue capsules from
BALB/c, and eight tissue capsules from MRL mice (eight
capsules/strain, total 24 capsules). Of these, RNA was
extracted from three capsules/mouse strain (total nine
capsules/three strains of mice). The five remaining capsules
from each strain of mice (total 15 capsules) were snap
frozen, embedded in optimal cutting temperature, and
used for histochemical analysis as described in the Method
section.
Expression profiling of tissue capsules
Total RNA was isolated from the freshly harvested
tissue capsules from each stain of mice with TRIzol reagent
(Invitrogen, Carlsbad, Calif) and further purified by
RNeasy mini kit (Qiagen, Germantown, Md) according to
the manufacturer’s instructions. RNA was resuspended in
DEPC treated distilled water and further purified using
RNA TackTMResin (Ultraspec-II RNA Isolation System;
Biotecx, Houston, Tex) according to the manufacturer’s
instructions. After purification, an aliquot of total RNAwas
electrophoresed (2.0% agarose gel) and visualized by stain-
ing with ethidium bromide to confirm the absence of
significant degradation. First strand cDNA was synthesized
from 5g of total RNA from each sample in the presence of
Cy5 or Cy3 dCTP, respectively. Aliquots (200 L) of the
mixture were hybridized onto Affymetrix GeneChip
Mouse ExpressionMicroarrayMOE-430 (22,000 cDNAand ESTs; Affymetrix, Santa Clara, Calif) according to the
manufacturer’s instructions using a GeneChip Hybridiza-
tion Oven 640 (Affymetrix). The microarray analysis was
performed in the Microarray Core Facility at Cedars-Sinai
Medical Center.
Data processing
Image acquisition of the mouse oligo microarrays was
performed on an Agilent G2565AA Microarray Scanner
System (Agilent Technologies, Santa Clara, Calif), and
feature extraction was performed with Agilent feature ex-
traction software (version A.6.1.1; Agilent Technologies).
Normalization was carried out using a locally weighted
scatterplot smoothing algorithm. Dye-normalized signals
of Cy3 and Cy5 channels were used in calculating log
ratios. Features with a reference value of 2.5 standard
deviations for the negative control were regarded as missing
values. Those features with values in at least two-thirds of
the experiments and present in at least one of the replicates
were retained for further analysis. Reproducibility of mi-
croarray results, as measured by the variation between
arrays for signal intensities, was assessed using box plots
(GeneData, San Francisco, Calif). Heat maps were gener-
ated using HeatMap Builder software.1
To identify differentially expressed transcripts, pairwise
comparison analysis was carried out with a Data Mining
Tool 3.0 (Affymetrix). This analysis compares the differ-
ences in values of perfect match to mismatch of each probe
pair in the baseline array to its matching probe on the
experimental array. P values were determined by the Wil-
coxon signed rank test and denoted as an increase, a de-
crease, or no change. Analysis also provides the signal log
ratio, which estimates the magnitude and direction of
change of a transcript when two arrays are compared. The
signal ratio output was converted into fold change, as
recommended by Affymetrix.
The genes enriched in the tissue capsule cells from the
three strains of mice were assigned to functional categories
using NetAffx.com and National Center for Biotechnology
Information databases. Gene lists were intersected by Uni-
gene number and by Gene Ontology to determine overlaps
and the function of highly expressed genes.
In vivo grafting of tissue capsules
For in vivo grafting of tissue capsule into abdominal
aorta, we used only the MRL mice due to the large size of
the animals, which made surgical procedure easier. The free
floating tissue capsule was removed from pertonium of
MRL mice, washed, and immersed in a heparinized saline
solution (100 units/mL) prior to transplantation. For
grafting, floating tissue capsules harvested from 21 MRL
mice were grafted into abdominal aorta of the same mice
(ie, the grafts are autografts). With the aid of an operating
microscope, the aorta was dissected from the left renal
artery to the iliac bifurcation; the small branches of the
aorta between these points were sealed with a cautery. An
end-to-end anastomosis technique involving a cuff-bridge
over a small nylon cannula was used to transplant the new
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abdominal aorta proximally and distally at the limits of the
dissection, two 9-0 silk loops were placed around the aorta
close to the vessel clamps at each end, and the aorta was
then divided between the suture loops. A nylon cannula
was sleeved into the proximal and distal segments of the
aorta, and secured by tying one set of the silk loops. The
tissue capsules were everted and grafted between the two
ends of the aorta by sleeving it over the aortic cuff and nylon
cannula and securing it with the second 9-0 silk loop per
Campbell’s protocol.2 The distal clamp was removed to
allow the graft to fill with blood under low pressure and to
check for leakages, followed by removal of the proximal
clamp to allow blood flow under full pressure. The perito-
neum and skin were closed with interrupted sutures, and
the mice were allowed to recover. Heparin was not given to
the animals at any time during the experiments.
We used two positive controls; vein grafts and arterial
grafts. For the arterial and vein grafts, thoracic aorta and
vena cava respectively from donor MRL mice were har-
vested and grafted into abdominal aorta of the recipient
MRLmice; thus, the grafts are isografts. Vein isografts were
performed by harvesting a segment of inferior vena cava
from donor mice, and grafting it into the abdominal aorta
of the recipient mice. Similarly, for the arterial grafts, a
segment of the thoracic aorta was harvested from donor
mice and grafted into the recipient mice using the same
surgical technique described above. For the negative con-
trol group (five mice/strain), the abdominal aorta was
occluded by double ligation with 9-0 silk. See the Table for
number of grafts and survival rate/patency rate.
Perfusion of grafts
The grafts were harvested at the indicated time after
implantation. The physical activity of mice was moni-
tored daily after implantation. The high frequency micro-
ultrasound was employed to determine the patency of the
abdominal grafts using the Vevo 770 (VisualSonics, To-
ronto, Ontario, Canada) micro-imaging system with the
RMV 706 scan head at a center frequency of 30 MHz and
10% power. This system provided a lateral resolution of 100
m and an axial resolution of 40 m. Laser Doppler
imaging was used to monitor perfusion of distal femoral
artery, essentially as described before.3Tissue preparation and histomorphometric analysis
We stained five tissue capsules block/strain of mice for
expression of CD31, smooth muscle -actin, MOMA-2,
and collagen. For immunohistochemistry, frozen sections
taken from all groups of mice were prepared, and every fifth
section (8 m) was stained with antibodies specific for
smooth muscle cell-specific marker (anti-smooth muscle
-actin antibody), endothelial cells (anti-CD31 antibody),
and macrophages (anti-MOMA-2 antibody) essentially as
described.4-7 All antibodies were obtained from Dako
(Glostrup, Denmark). Masson’s tri-chrome staining and
Movat staining were used to assess composition of the
frozen sections. To stain vein grafts or arterial grafts, the
grates were snapped frozen after harvest (n  5 mouse/
graft), embedded in optimal cutting temperature, sec-
tioned, and stained with indicated antibodies.
Statistical analysis
One-way analysis of variance was used to compare the
means of three or more groups, followed by Bonferroni
post-hoc test. Prism 3.0 software (Graph Pad, La Jolla,
Calif) was used for all calculations. All data are represented
as mean  SEM. Values with P  .05 were considered
statistically significant.
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